|
![]() |
![]() ![]() |
![]() |
|
||
![]() |
![]() |
Q3 Report A few things have improved, but still pretty iffy for now. Research expenses down due to moving them to Sanofi. G&A should start dropping due to reduction in facility expenses and lower headcount. They have enough money for 6 months or so. |
![]() ![]() ![]() ![]() |
return to message board, top of board |